Gemcitabine at fixed dose-rate in patients with advanced soft tissue sarcomas: a mono-institutional phase II study

[1] Jemal A(2006)Cancer statistics, 2006 CA Cancer J Clin 56 106-130

[2] Siegel R(2002)The use of chemotherapy in soft-tissue sarcomas Oncologist 7 348-359

[3] Ward E(1995)Gemcitabine: metabolism, mechanism of action, and self-potentiation Semin Oncol 22 3-10

[4] Spira AI(2000)Gemcitabine in soft tissue or bone sarcoma resistant to standard chemotherapy: a phase II study Cancer Chemother Pharmacol 45 177-181

[5] Ettinger DS(2000)Phase II trial of gemcitabine in patients with pretreated advanced soft tissue sarcomas Anticancer Drugs 11 325-329

[6] Plunkett W(2001)Phase II clinical investigation of gemcitabine in advanced soft tissue sarcomas and window evaluation of dose rate on gemcitabine triphosphate accumulation J Clin Oncol 19 3483-3489

[7] Huang P(2001)Phase I study of low dose continuous infusion gemcitabine in sarcoma patients [abstract] Proc Am Soc Clin Oncol 20 2935-224

[8] Xu YZ(2002)Gemcitabine-containing chemotherapy in the treatment of patients with advanced soft tissue sarcoma Tumordiagn Ther 23 219-647

[9] Heinemann V(2004)Phase II trial of gemcitabine as second-line chemotherapy of uterine leiomyosarcoma: a Gynecologic Oncology Group (GOG) Study Gynecol Oncol 92 644-498

[10] Grunewald R(1991)A phase I clinical, plasma and cellular pharmacology study of gemcitabine J Clin Oncol 9 491-119

[1] Jemal A(2006)Cancer statistics, 2006 CA Cancer J Clin 56 106-130

[2] Siegel R(2002)The use of chemotherapy in soft-tissue sarcomas Oncologist 7 348-359

[3] Ward E(1995)Gemcitabine: metabolism, mechanism of action, and self-potentiation Semin Oncol 22 3-10

[4] Spira AI(2000)Gemcitabine in soft tissue or bone sarcoma resistant to standard chemotherapy: a phase II study Cancer Chemother Pharmacol 45 177-181

[5] Ettinger DS(2000)Phase II trial of gemcitabine in patients with pretreated advanced soft tissue sarcomas Anticancer Drugs 11 325-329

[6] Plunkett W(2001)Phase II clinical investigation of gemcitabine in advanced soft tissue sarcomas and window evaluation of dose rate on gemcitabine triphosphate accumulation J Clin Oncol 19 3483-3489

[7] Huang P(2001)Phase I study of low dose continuous infusion gemcitabine in sarcoma patients [abstract] Proc Am Soc Clin Oncol 20 2935-224

[8] Xu YZ(2002)Gemcitabine-containing chemotherapy in the treatment of patients with advanced soft tissue sarcoma Tumordiagn Ther 23 219-647

[9] Heinemann V(2004)Phase II trial of gemcitabine as second-line chemotherapy of uterine leiomyosarcoma: a Gynecologic Oncology Group (GOG) Study Gynecol Oncol 92 644-498

[10] Grunewald R(1991)A phase I clinical, plasma and cellular pharmacology study of gemcitabine J Clin Oncol 9 491-119